Omers Administration Corp Protalix Bio Therapeutics, Inc. Call Options Transaction History
Omers Administration Corp
- $11 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
69Shares Held
8.26MCall Options Held
227KPut Options Held
54.5K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.19MShares$2.02 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny963KShares$1.64 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA859KShares$1.46 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL685KShares$1.16 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0615KShares$1.05 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $84.6M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...